Cambridge Orthopaedic Labs announced first commercial case performed with PolyArmour (PA), a non-invasive external fracture fixation system,
The PolyArmour system is designed to allow the surgeon to achieve clinically demonstrated performance at the level of a surgical intervention without a surgical procedure. PolyArmour was cleared by FDA in 2022 and launched in early March 2023.
PolyArmour utilizes the concepts of three-point fixation, dynamization and conformity described in the orthopedic literature, but instead of ridged casting materials or invasive surgical plates, PA applies a set of linkages that can be adjusted to fit any patient anatomy at any suitable fracture location. The materials used in the PA system are biocompatible and radiolucent. The PA linkages are contained in multiple cuffs, lined with biocompatible spacer fabric to apply appropriate compression to a fracture site without compromising blood flow of nerve function. Application of the PA cuff technology linked by high-strength carbon rods (again adaptable to the patient’s anatomy) stabilizes a fracture that has undergone closed reduction under x-ray or fluoroscopy and holds the reduced fracture in place throughout the healing process.
Cambridge Orthopaedic Labs announced first commercial case performed with PolyArmour (PA), a non-invasive external fracture fixation system,
The PolyArmour system is designed to allow the surgeon to achieve clinically demonstrated performance at the level of a surgical intervention without a surgical procedure. PolyArmour was cleared by FDA in...
Cambridge Orthopaedic Labs announced first commercial case performed with PolyArmour (PA), a non-invasive external fracture fixation system,
The PolyArmour system is designed to allow the surgeon to achieve clinically demonstrated performance at the level of a surgical intervention without a surgical procedure. PolyArmour was cleared by FDA in 2022 and launched in early March 2023.
PolyArmour utilizes the concepts of three-point fixation, dynamization and conformity described in the orthopedic literature, but instead of ridged casting materials or invasive surgical plates, PA applies a set of linkages that can be adjusted to fit any patient anatomy at any suitable fracture location. The materials used in the PA system are biocompatible and radiolucent. The PA linkages are contained in multiple cuffs, lined with biocompatible spacer fabric to apply appropriate compression to a fracture site without compromising blood flow of nerve function. Application of the PA cuff technology linked by high-strength carbon rods (again adaptable to the patient’s anatomy) stabilizes a fracture that has undergone closed reduction under x-ray or fluoroscopy and holds the reduced fracture in place throughout the healing process.
Copy to clipboard 
